Target
Tyrosine-protein kinase BTK [393-659]
Ligand
BDBM287428
Substrate
n/a
Meas. Tech.
Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET)
pH
6.5±n/a
Temperature
298.15±n/a K
IC50
<100±n/a nM
Comments
extracted
Citation
 Bonafoux, DDavis, HMFrank, KEFriedman, MMHerold, JMHoemann, MZHuntley, ROsuma, ASheppard, GSomal, GKVan Camp, JVan Epps, SAVasudevan, AWallace, GAWang, LWang, LWang, ZWilson, NSXu, X Primary carboxamides as BTK inhibitors US Patent  US9567339 Publication Date 2/14/2017 
Target
Name:
Tyrosine-protein kinase BTK [393-659]
Synonyms:
AGMX1 | ATK | BPK | BTK | BTK_HUMAN | Tyrosine-protein kinase BTK
Type:
Enzyme Catalytic Domain
Mol. Mass.:
31165.48
Organism:
Homo sapiens (Human)
Description:
aa 393-659
Residue:
267
Sequence:
GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES
  
Inhibitor
Name:
BDBM287428
Synonyms:
US9567339, Example E.9.27
Type:
Small organic molecule
Emp. Form.:
C22H23N5O3
Mol. Mass.:
405.4497
SMILES:
NC(=O)c1ccc([C@@H]2CCN(C2)C(=O)C=C)c2cc([nH]c12)-c1cc2COCCn2n1 |r|
Structure:
Search PDB for entries with ligand similarity: